Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Perras

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Gynecologic Oncology|April 1, 1994
Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability assayM Untch, B U Sevin, J P Perras, et al.
Gynecologic Oncology|November 1, 1992
Chemosensitivity to the new anthracycline pirarubicin and other chemotherapeutic agents in primary and recurrent ovarian tumors in vitroM Untch, B U Sevin, J P Perras, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1997
Modulation of cisPlatin cytotoxicity by interleukin-1 alpha and resident tumor macrophagesP G Braunschweiger, V S Basrur, D Cameron, et al.
Breast Cancer Research and Treatment|October 1, 1993
Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-cell viability assayO R Koechli, B U Sevin, J P Perras, et al.
Anti-Cancer Drugs|February 1, 1995
In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasmsO R Koechli, G N Schaer, B U Sevin, et al.
Gynecologic Oncology|October 1, 1991
Cell kinetic perturbations after irradiation and caffeine in the BG-1 ovarian carcinoma cell lineE H Wolloch, B U Sevin, J P Perras, et al.
Oncology|January 1, 1992
Rationale of combining radiation and interferon for the treatment of cervical cancerR Angioli, B U Sevin, J P Perras, et al.
Cancer|May 1, 1993
Enhancement of progesterone receptor levels by interferons in AE-7 endometrial cancer cellsR Angioli, M Untch, B U Sevin, et al.
Cancer|June 1, 1993
In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell linesR Angioli, B U Sevin, J P Perras, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Gynecologic Oncology|April 1, 1994
Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability assayM Untch, B U Sevin, J P Perras, et al.
Gynecologic Oncology|November 1, 1992
Chemosensitivity to the new anthracycline pirarubicin and other chemotherapeutic agents in primary and recurrent ovarian tumors in vitroM Untch, B U Sevin, J P Perras, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1997
Modulation of cisPlatin cytotoxicity by interleukin-1 alpha and resident tumor macrophagesP G Braunschweiger, V S Basrur, D Cameron, et al.
Breast Cancer Research and Treatment|October 1, 1993
Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-cell viability assayO R Koechli, B U Sevin, J P Perras, et al.
Anti-Cancer Drugs|February 1, 1995
In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasmsO R Koechli, G N Schaer, B U Sevin, et al.
Gynecologic Oncology|October 1, 1991
Cell kinetic perturbations after irradiation and caffeine in the BG-1 ovarian carcinoma cell lineE H Wolloch, B U Sevin, J P Perras, et al.
Oncology|January 1, 1992
Rationale of combining radiation and interferon for the treatment of cervical cancerR Angioli, B U Sevin, J P Perras, et al.
Cancer|May 1, 1993
Enhancement of progesterone receptor levels by interferons in AE-7 endometrial cancer cellsR Angioli, M Untch, B U Sevin, et al.
Cancer|June 1, 1993
In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell linesR Angioli, B U Sevin, J P Perras, et al.
Pageof 3